Literature DB >> 10906179

Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses.

B Yuan1, S Campbell, E Bacharach, A Rein, S P Goff.   

Abstract

The p12 region of the Moloney murine leukemia virus (M-MuLV) Gag protein contains a PPPY motif important for efficient virion assembly and release. To probe the function of the PPPY motif, a series of insertions of homologous and heterologous motifs from other retroviruses were introduced at various positions in a mutant gag gene lacking the PPPY motif. The assembly defects of the PPPY deletion mutant could be rescued by insertion of a wild-type PPPY motif and flanking sequences at several ectopic positions in the Gag protein. The late assembly domain (L-domain) of Rous sarcoma virus (RSV) or human immunodeficiency virus type 1 (HIV-1) could also fully or partially restore M-MuLV assembly when introduced into matrix, p12, or nucleocapsid domains of the mutant M-MuLV Gag protein lacking the PPPY motif. Strikingly, mutant viruses carrying the RSV or the HIV-1 L-domain at the original location of the deleted PPPY motif were replication competent in rodent cells. These data suggest that the PPPY motif of M-MuLV acts in a partially position-independent manner and is functionally interchangeable with L-domains of other retroviruses. Electron microscopy studies revealed that deletion of the entire p12 region resulted in the formation of tube-like rather than spherical particles. Remarkably, the PPPY deletion mutant formed chain structures composed of multiple viral particles linked on the cell surface. Many of the mutants with heterologous L-domains released virions with wild-type morphology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10906179      PMCID: PMC112246          DOI: 10.1128/jvi.74.16.7250-7260.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release.

Authors:  H G Göttlinger; T Dorfman; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

2.  Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope p15 sequences in precursor polypeptides.

Authors:  L J Arcement; W L Karshin; R B Naso; G Jamjoom; R B Arlinghaus
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

3.  Form, function, and use of retroviral gag proteins.

Authors:  J W Wills; R C Craven
Journal:  AIDS       Date:  1991-06       Impact factor: 4.177

4.  Standardized and simplified nomenclature for proteins common to all retroviruses.

Authors:  J Leis; D Baltimore; J M Bishop; J Coffin; E Fleissner; S P Goff; S Oroszlan; H Robinson; A M Skalka; H M Temin
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

5.  Sequence and spacing requirements of a retrovirus integration site.

Authors:  J Colicelli; S P Goff
Journal:  J Mol Biol       Date:  1988-01-05       Impact factor: 5.469

6.  Host cell dependence of viral morphology.

Authors:  P C Roberts; R W Compans
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  An immunofluorescence study of influenza virus filament formation.

Authors:  J C Cox; A W Hampson; R C Hamilton
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  "gag" polyprotein precursors of Rauscher murine leukemia virus.

Authors:  L J Arcement; W L Karshin; R B Naso; R B Arlinghaus
Journal:  Virology       Date:  1977-09       Impact factor: 3.616

10.  Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro.

Authors:  L S Ehrlich; B E Agresta; C A Carter
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

View more
  108 in total

Review 1.  Ubiquitin in retrovirus assembly: actor or bystander?

Authors:  V M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 2.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Role of ESCRT-I in retroviral budding.

Authors:  Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Nucleic acid-independent retrovirus assembly can be driven by dimerization.

Authors:  Marc C Johnson; Heather M Scobie; Yu May Ma; Volker M Vogt
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

5.  Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.

Authors:  S M Joshi; V M Vogt
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  TANK-binding kinase 1 attenuates PTAP-dependent retroviral budding through targeting endosomal sorting complex required for transport-I.

Authors:  Qi Da; Xuanming Yang; Youli Xu; Guangxia Gao; Genhong Cheng; Hong Tang
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

7.  The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process.

Authors:  Isabelle Le Blanc; Marie-Christine Prévost; Marie-Christine Dokhélar; Arielle R Rosenberg
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Genetic footprinting of a retroviral Gag gene suggests an important role in virus replication.

Authors:  Alan Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-06       Impact factor: 11.205

Review 9.  Properties and functions of the nucleocapsid protein in virus assembly.

Authors:  Delphine Muriaux; Jean-Luc Darlix
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

10.  Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.

Authors:  Juan Martin-Serrano; Anton Yarovoy; David Perez-Caballero; Paul D Bieniasz; Anton Yaravoy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.